Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Lilly asks people who took compounded tirzepatide for their medical records
Eli Lilly (NYSE:LLY) is taking the unusual step of asking people who took compounded versions of their drug tirzepatide, marketed as Zepbound for weight loss and Mounjaro for type 2 diabetes, for medical records to examine potential safety concerns.
Lilly Wants Records From People Who Took Weight-Loss Knockoffs
Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their medical records as it continues to build a case against businesses selling the compounded drugs.
Eli Lilly wants records of people who took copies of its weight-loss drug
We recently learned that you took one of our products from a compounded pharmacy,” Lilly wrote in a letter viewed by Bloomberg News. “We would appreciate if you could complete the enclosed form and sign the Authorisation for Release of Medical Information so that we can obtain more details from the treating physician around your experience.
Medindia
2d
How Rapid Weight Loss from Tirzepatide Triggered a Thyroid Crisis
Can weight loss medications trigger a thyroid crisis? In this case, rapid weight loss from tirzepatide led to ...
MedPage Today
7d
Tirzepatide Yields Greater Weight Loss in Women Than Men
Across all studies and doses, females lost up to 24.6% of body weight from baseline whereas men lost a maximum of 18.1% of ...
3d
on MSN
GLP-1 pills are coming, and they could revolutionize weight-loss treatment
At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...
6d
Who is more likely to lose weight on tirzepatide and why?
A new study explores the reasons why tirzepatide, the once-weekly injection used to treat obesity and type 2 diabetes, is ...
7d
Women could experience greater weight loss with Mounjaro, but also more side effects, study finds
A new study found that women using the weight loss drug tirzepatide (Mounjaro) lost more weight than men, but experienced ...
Knowridge
1d
New weight-loss drug shows promise in reducing diabetes risk
Researchers from the University of Liverpool have found that the weight-loss drug tirzepatide could significantly reduce the ...
8d
on MSN
Weight-loss drug Zepbound may be more effective in women
The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis.
6d
on MSN
Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes
Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...
19d
Weight Loss Drug Reduces Diabetes Risk by 94 Percent in Clinical Trial
Tirzepatide, the active ingredient in the popular weight loss drug Zepbound, has been shown to reduce the risk of developing ...
Daily
7d
Tirzepatide effects greater weight loss among women compared to men, claims study
All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body ...
Hollywood Life
2d
Affordable Semaglutide and Tirzepatide Weight Management Solutions Now Available in California for Hollywood Hopefuls
This partnership aims to extend The A-List Clinic’s reach, making it easier for people in the entertainment industry to learn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
Mounjaro
Wegovy
Feedback